Incidence of acute myeloid leukemia and hepatocellular carcinoma in mice irradiated with 1 GeV/nucleon 56Fe Ions

Radiation Research

Volumn 172, Issue 2, 2009, Pages 213-219

  Weil, Michael M ^a   Bedford, Joel S ^a   Bielefeldt Ohmann, Helle ^a   Ray, F Andrew ^a   Genik, Paula C ^a   Ehrhart, Eugene J ^a   Fallgren, Christina M ^a   Hailu, Fitsum ^a   Battaglia, Christine L R ^a   Charles, Brad ^a   Callan, Matthew A ^a   Ullrich, Robert L ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IRON; HEAVY ION;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INCIDENCE; CANCER RISK; COSMIC RADIATION; GAMMA RADIATION; IRRADIATION; LEUKEMOGENESIS; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; NUCLEON; PRIORITY JOURNAL; ANIMAL; ANIMAL DISEASE; INCIDENCE; LIVER TUMOR; MALE; METHODOLOGY; MYELOID LEUKEMIA; RADIATION DOSE; RADIATION INJURY; RADIATION RESPONSE; RISK ASSESSMENT; RISK FACTOR; STATISTICS; WHOLE BODY RADIATION;

MUS;

ANIMALS; CARCINOMA, HEPATOCELLULAR; COSMIC RADIATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; HEAVY IONS; INCIDENCE; IRON; LEUKEMIA, MYELOID; LIVER NEOPLASMS; MALE; MICE; NEOPLASMS, RADIATION-INDUCED; RADIATION DOSAGE; RISK ASSESSMENT; RISK FACTORS; WHOLE-BODY IRRADIATION;

EID: 70349334607     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR1648.1     Document Type: Article

References (39)

1. National Research Council, Radiation Hazards to Crews of Interplanetary Missions: Biological Issues and Research Strategies. National Academy Press, Washington, DC, 1996.
2. United Nations Scientific Committee on the Effects of Atomic Radiation, UNSCEAR Report 2000: Sources and Effects of Ionizing Radiation. United Nations, New York, 2000.
3. S. M. Smith, M. M. Le Beau, D. Huo, T. Karrison, R. M. Sobecks, J. Anastasi, J. W. Vardiman, J. D. Rowley and R. A. Larson, Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series. Blood 102, 43-52 (2003).
4. R. H. Mole, D. G. Papworth and M. J. Corp, The dose-response for x-ray induction of myeloid leukemia in male CBA/H mice. Br. J. Cancer 47, 285-291 (1983).
5. R. L. Ullrich and R. J. Preston, Myeloid leukemia in male RFM mice following irradiation with fission spectrum neutrons or gamma rays. Radiat. Res. 109, 165-170 (1987).
6. A. C. Upton, M. L. Randolph, J. W. Conklin, G. S. Melville, F. P. Conte and J. A. Sproul, Late effects of fast neutrons and gamma-rays in mice as influenced by dose rate of irradiation Induction of neoplasia. Radiat. Res. 41, 467-491 (1970).
7. J. I. Azumi and L. Sachs, Chromosome mapping of the genes that control differentiation and malignancy in myeloid leukemic cells. Proc. Natl. Acad. Sci. USA 74, 253-257 (1977).
8. N. Haran-Ghera, Radiation induced deletion of chromosome 2 in myeloid leukemogenesis. Curr. Top. Microbiol. Immunol. 149, 35-41 (1989).
9. I. Hayata, M. Seki, K. Yoshida, K. Hirashima, T. Sado, J. Yamagiwa and T. Ishihara, Chromosomal aberrations observed in 52 mouse myeloid leukemias. Cancer Res. 43, 367-373 (1983).
10. A. R. J. Silver, J. Boultwood, W. K. Masson, D. Malowany and R. Cox. Studies on radiation myeloid leukaemogenesis in the mouse. In Radiation Research, Vol. 2 (E. M. Fielden, J. F. Fowler, J. H. Hendry and and D. Scott, Eds.), pp. 495-500. Taylor & Francis, London, 1987.
11. R. H. Mole, Dose-response relationships. In Radiation Carcinogenesis: Epidemiology and Biologic Significance (J. D. Boice, Jr. and and J. F. Fraumeni, Jr., Eds.), pp. 263-271. Raven Press, New York, 1984.
12. 56Fe ions, X rays or γ rays. Part I. Experimental observations. Radiat. Res. 171, 474-483 (2009).
13. A. Burich, R. Hershberg, K. Waggie, W. Zeng, T. Brabb, G. Westrich, J. L. Viney and L. Maggio-Price, Helicobacter-induced inflammatory bowel disease in IL-10- and T cell-deficient mice. Am. J. Physiol. Gastrointest. Liver Physiol. 281, G764-G778 (2001).
14. L. Maggio-Price, D. Shows, K. Waggie, A. Burich, W. Zeng, S. Escobar, P. Morrissey and J. L. Viney, Helicobacter bilis infection accelerates and H. hepaticus infection delays the development of colitis in multiple drug resistance-deficient (mdr1a2/2) mice. Am. J. Pathol. 160, 739-751 (2002).
15. H. E. Walburg, Jr., G. E. Cosgrove and A. C. Upton, Influence of microbial environment on development of myeloid leukemia in x-irradiated RFM mice. Int. J. Cancer 3, 150-154 (1968).
16. R. J. M. Fry, P. Powers-Risius, E. L. Alpen, E. J. Ainsworth and R. L. Ullrich, High-LET radiation carcinogenesis. Adv. Space Res. 3, 241-248 (1983).
17. E. J. Ainsworth, Early and late mammalian responses to heavy charged particles. Adv. Space Res. 6, 153-165 (1986).
18. E. A. Blakely, F. O. H. Ngo, S. B. Curtis and C. A. Tobias, Heavy-ion radiobiology: Cellular studies. Adv. Radiat. Biol. 11, 295-389 (1984).
19. T. B. Borak and T. G. Stinchcomb, Quality factor calculations for neutron spectra below 4 MeV. Health Phys. 36, 687-693 (1979).
20. T. G. Stinchcomb and T. B. Borak, Neutron quality parameters versus energy below 4 MeV from microdosimetric calculations. Radiat. Res. 93, 1-18 (1983).
21. A. A. Edwards, D. C. Lloyd and R. J. Purrott, Dicentric chromosome aberration yield in human lymphocytes and radiation quality. A resume including recent results using alpha-particles. In Proceedings of the 7th Symposium on Microdosimetry, Vol. 2 (J. Booz, H. G. Ebert and H. D. Hartfiel Eds.), pp. 1263-1274. CEC, Brussels, 1981.
22. U. Madhvanath, M. R. Raju and L. S. Kelly, Survival of human lymphocytes after exposure to densely ionizing radiation. In Radiation and the Lymphatic System, pp. 125-139. ERDA Symposium Series 37, U.S. Energy Research and Development Administration, Washington, DC, 1976.
23. 56Fe ions, X rays or γ rays. Part II. Theoretical considerations based on microdosimetry and the initial induction of chromosome aberrations. Radiat. Res. 171, 484-493 (2009).
24. J. M. Ward, J. G. Fox, M. R. Anver, D. C. Haines, C. V. George, M. J. Collins, Jr., P. L. Gorelick, K. Nagashima, M. A. Gonda and J. M. Rice, Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species. J. Natl. Cancer Inst. 86, 1222-1227 (1994).
25. B. A. Diwan, M. Sipowicz, D. Logsdon, P. Gorelick, M. R. Anver, K. S. Kasprzak and L. M. Anderson, Marked liver tumorigenesis by Helicobacter hepaticus requires perinatal exposure. Environ. Health Perspect. 116, 1352-1356 (2008).
26. V. Covelli, V. Di Majo, M. Coppola and S. Rebessi, Neutron carcinogenesis in mice: a study of the dose-response curves. Radiat. Res. 128 (Suppl.), S114-S116 (1991).
27. J. B. Cologne, S. Tokuoka, G. W. Beebe, T. Fukuhara and K. Mabuchi, Effects of radiation on incidence of primary liver cancer among atomic bomb survivors. Radiat. Res. 152, 364-373 (1999).
28. E. S. Gilbert, N. A. Koshurnikova, M. Sokolnikov, V. F. Khokhryakov, S. Miller, D. L. Preston, S. A. Romanov, N. S. Shilnikova, K. G. Suslova and V. V. Vostrotin, Liver cancers in Mayak workers. Radiat. Res. 154, 246-252 (2000).
29. G. S. Lipshutz, T. V. Brennan and R. S. Warren, Thorotrast-induced liver neoplasia: a collective review. J. Am. Coll. Surg. 195, 713-718 (2002).
30. J. D. Harrison and C. R. Muirhead, Quantitative comparisons of cancer induction in humans by internally deposited radionuclides and external radiation. Int. J. Radiat. Biol. 79, 1-13 (2003).
31. L. M. Kelly and D. G. Gilliland, Genetics of myeloid leukemias. Annu. Rev. Genomics Hum. Genet. 3, 179-198 (2002).
32. D. Metcalf, The Charlotte Friend Memorial Lecture. The role of hematopoietic growth factors in the development and suppression of myeloid leukemias. Leukemia 11, 1599-1604 (1997).
33. W. D. Cook, B. J. McCaw, C. Herring, D. L. John, S. J. Foote, S. L. Nutt and J. M. Adams, PU.1 is a suppressor of myeloid leukemia, inactivated in mice by gene deletion and mutation of its DNA binding domain. Blood 104, 3437-3444 (2004).
34. A. Silver, J. Moody, R. Dunford, D. Clark, S. Ganz, R. Bulman, S. Bouffler, P. Finnon, E. Meijne and R. Cox, Molecular mapping of chromosome 2 deletions in murine radiation-induced AML localizes a putative tumor suppressor gene to a 1.0 cM region homologous to human chromosome segment 11p11-12. Genes Chromosomes Cancer 24, 95-104 (1999).
35. F. Farinati, R. Cardin, M. Bortolami, P. Burra, F. P. Russo, M. Rugge, M. Guido, A. Sergio and R. Naccarato, Hepatitis C virus: from oxygen free radicals to hepatocellular carcinoma. J. Viral Hepat. 14, 821-829 (2007).
36. M. H. Roudkenar, L. Li, T. Baba, Y. Kuwahara, H. Nakagawa, L. Wang, S. Kasaoka, Y. Ohkubo, K. Ono and M. Fukumoto, Gene expression profiles in mouse liver cells after exposure to different types of radiation. J. Radiat. Res. (Tokyo) 49, 29-40 (2008).
37. S. B. Curtis, E. G. Luebeck, W. D. Hazelton and S. H. Moolgavkar, The role of promotion in carcinogenesis from protracted high-LET exposure. Phys. Med. 17 (Suppl. 1), 157-160 (2001).
38. 224Ra: protraction effects from promotion. Radiat. Environ. Biophys. 44, 61-67 (2005).
39. R. L. Ullrich, The rate of progression of radiation-transformed mammary epithelial cells is enhanced after low-dose-rate neutron irradiation. Radiat. Res. 105, 68-75 (1986).